Biofrontera, Inc. (NASDAQ: BFRI) Receives U.S. Patent Issuance for Innovative Illumination Protocol
Biofrontera, Inc. (NASDAQ: BFRI) is engaged as a biopharmaceutical company, which is focused on the research, development, testing and commercialization ...